• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Combating MS in Men

A NEW TESTOSTERONE GEL shows promise for combating the effects of multiple sclerosis in men. Dr. Rhonda Voskuhl, director of UCLA’s Multiple Sclerosis Program, and Dr. Nancy Sicotte, assistant professor of neurology, found that application of the testosterone gel reduced symptoms, slowed brain degeneration and boosted muscle mass in 10 men with relapsing-remitting MS, the most common form of the disease. In relapsing-remitting MS, episodes of neurological symptoms, such as numbness or disturbed balance and gait, are followed by symptom-free periods of remission.

For the first six months of the study, the researchers monitored the men’s symptoms but did not treat them. For the next 12 months, each man applied 10 grams of a gel containing 100 milligrams of testosterone once a day to his upper arms. “After a year, we saw an improvement in cognitive performance and a slowing of brain deterioration,” says Dr. Voskuhl. During the fi nal nine months of gel application, in fact, the rate of brain deterioration in the men slowed by 67 percent. The men’s muscle mass also increased an average of 3.74 pounds during the treatment phase. The Archives of Neurology reported the findings in May.

“Another optimistic observation was that the testosterone protected against brain atrophy without causing a significant anti-inflammatory effect,” says Dr. Voskuhl. “This suggests that the protection provided by testosterone may not be limited to MS. It may also apply to other non-inflammatory neurodegenerative diseases.”

Like many other autoimmune diseases, MS is less common in men than in women, affecting about three women to every man. Dr. Voskuhl suspects that sex hormones and/or sex chromosomes may explain the higher incidence in women.


Previous
Proteins in the Key of G
Next
Research Revolution


YOU ARE VIEWING

Winter 2008

Winter 2008
Printable PDF
IN THIS ISSUE
  • New Beginnings
  • Proteins in the Key of G
  • Combating MS in Men
  • Research Revolution
  • Hail to the Chief
  • UCLA Ranks No. 3 in U.S.!
  • D-Day at UCLA
  • Cueing the Brain
  • Of Mice and Men
  • Hope for Wounded Warriors
  • Dr. Richard J. Shemin
  • Heart of Gold
  • Cardiology and Cardiac Surgery at UCLA
  • Profile in Courage
  • Clemente's Anatomy
  • Anatomy’s Next Wave
  • Anatomy From the Inside Out
  • Gray Matters
  • Remembering Dr. Dignam 1921-2006 / In Memoriam / Awards
  • An Apple for Teacher / Books Without Borders
  • Celebrate!
  • A Gift to Accelerate Stem-Cell Research / In Memoriam
  • Epilogue
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth